Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/1996
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013478A1 Mono- or polyenic carboxylic acid derivative
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996CA2202988A1 Mono- or polyenic carboxylic acid derivatives
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996CN1121823A Method for producing medicine for treatment of chronic osteomyelitis
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D
04/1996
04/30/1996US5512581 Antiinflammatory agent
04/30/1996US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists
04/30/1996US5512552 Bone resorption inhibitor; osteoporosis
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/24/1996WO1997014681A1 Heterocyclic compounds as h+-atpases
04/24/1996EP0707850A1 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
04/24/1996EP0707566A1 Novel structural analogues of vitamin d
04/24/1996CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them
04/23/1996US5510498 Benzothiophene compounds, intermediates, compositions, and methods
04/23/1996US5510370 Osteoporosis, osteoarthritis treatment
04/23/1996US5510358 Osteoporosis
04/23/1996US5510357 Benzothiophene compounds as anti-estrogenic agents
04/17/1996CN1120549A Calcitonin analogue and use thereof
04/17/1996CN1031570C Process for preparation of pyrazolopyridine compound
04/11/1996WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof
04/10/1996EP0705839A1 Imidobisphosphoric acids, process for their preparation and their use
04/10/1996EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production
04/10/1996CN1120337A Process for production of an imidazole derivative
04/10/1996CN1120314A Method and composition for treatment of osteoporosis
04/10/1996CN1120304A Method and composition for treatment of osteoporosis
04/10/1996CN1120039A Acylated aminoalknimidazoles and-triazoles
04/10/1996CN1119940A Combination treatment for inhibiting bone loss
04/09/1996US5506249 Antiinflammatory, antiproliferative and antitumor activity
04/09/1996US5506243 Sulfonamide derivatives
04/09/1996US5506242 Arylsufonamido-substituted hydroxamic acids
04/09/1996US5506133 Polypeptide
04/04/1996WO1996009819A1 Inhibitor for bone resorption by osteoclast
04/03/1996EP0704219A2 A novel osteoblastic proliferative factor
04/03/1996EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same
04/03/1996EP0703897A1 Lipoxin compounds
04/03/1996EP0703785A1 Methods for treating muscle diseases and disorders
04/03/1996EP0535091B1 Osteoinductive pharmaceutical formulations
04/03/1996CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol
03/1996
03/31/1996CA2159257A1 Interleukin-1 production inhibiting compound
03/28/1996WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/28/1996WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods
03/28/1996WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
03/28/1996CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/28/1996CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods
03/27/1996EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them
03/27/1996EP0702954A2 Calcium dietary supplement
03/27/1996EP0702559A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/27/1996EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions
03/27/1996CN1119457A Bone stimulating factor
03/27/1996CA2158811A1 Calcium dietary supplement
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501861 Carbohydrates
03/22/1996CA2158591A1 Fatty acid treatment
03/21/1996WO1996008480A1 Neurokinin antagonists
03/21/1996CA2200083A1 Neurokinin antagonists
03/20/1996EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac
03/19/1996US5500429 Cardiovascular
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996WO1996007416A1 Estrogens and parathyroid hormone for treating osteoporosis
03/14/1996WO1996007402A1 Triphenylethylenes for the prevention and treatment of osteoporosis
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996CA2199250A1 Estrogens and parathyroid hormone for treating osteoporosis
03/13/1996EP0544880B1 Method of preparing diacetyl rhein
03/12/1996US5498617 Bone disorders
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/06/1996EP0699673A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/06/1996EP0699672A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/05/1996US5496814 Steroids for bone disorders and oxidation resistance
03/05/1996US5496801 Storage stability, mannitol, citric acid buffer
03/01/1996CA2157236A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/01/1996CA2157235A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
02/1996
02/29/1996WO1996006169A1 Human chemokine beta-9
02/29/1996WO1996006087A1 Bicyclic compounds
02/29/1996WO1996005855A1 Cartilage disease remedy
02/29/1996WO1996005851A1 Use of tasteless, hydrolysed collagen and agent containing the same
02/29/1996WO1996005842A1 Intravenous alendronate formulations
02/29/1996WO1996005829A1 Methods of maintaining teeth and oral bone
02/29/1996CA2198206A1 Human chemokine beta-9
02/29/1996CA2198108A1 Methods of maintaining teeth and oral bone
02/28/1996EP0698094A1 Bmp-11 compositions